Alprenoxime
Alprenoxime is a beta blocker.[1] It is a prodrug to alprenolol.[1]
Molecular Weight | 262.34738 g/mol |
Molecular Formula | C15H22N2O2 |
XLogP3 | 3.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 8 |
Exact Mass | 262.168128 g/mol |
Monoisotopic Mass | 262.168128 g/mol |
Topological Polar Surface Area | 53.8 A^2 |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 290 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently-Bonded Unit Count | 1 |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C15H22N2O2 |
Molar mass | 262.35 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
References
- Prokai L, Wu WM, Somogyi G, Bodor N (May 1995). "Ocular delivery of the beta-adrenergic antagonist alprenolol by sequential bioactivation of its methoxime analogue". Journal of Medicinal Chemistry. 38 (11): 2018–20. doi:10.1021/jm00011a021. PMID 7783133.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.